Immune Therapy Holdings

🗓 Founded 2005👥 2 employees💰 Last funded Sep 2010
Biotechnology Research🌐 ithgroup.eu
Website LinkedIn
ITH is a biotech company located at the Karolinska Institutet and Karolinska University Hospital, dedicated to innovating the next generation of personalized therapeutics and diagnostics for patients with immune related diseases. The company's research & development is focused on its award-winning Tailored Leukapheresis (TLA) immunotherapy for Immune Mediated Inflammatory Diseases - which has been developed with the support of the European Union, Swedish Research Council, and Swedish Governmental Agency for Innovation Systems.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2005
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
1
Frequently asked questions
Who invested in Immune Therapy Holdings?
Immune Therapy Holdings has 1 investors on record on gritt.io, 1 mid-stage.
When did Immune Therapy Holdings last raise funding?
The most recent investment in Immune Therapy Holdings recorded on gritt.io was in September 2010.
When was Immune Therapy Holdings founded?
Immune Therapy Holdings was founded in 2005.
What industry is Immune Therapy Holdings in?
Immune Therapy Holdings operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.